Sort   by:  
 Page size 
UnknownMutations in RASA1 and GDF2 identified in patients with clinical features of hereditary hemorrhagic telangiectasia.
Not available
S-EPMC4785548 | biostudies-literature
UnknownPazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia.
Not available
S-EPMC6510884 | biostudies-literature
UnknownLAsting Symptoms after Oesophageal Resectional Surgery (LASORS): multicentre validation cohort study.
Not available
S-EPMC11843645 | biostudies-literature
UnknownHemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia.
Not available
S-EPMC4415515 | biostudies-literature
UnknownAssociation of common candidate variants with vascular malformations and intracranial hemorrhage in hereditary hemorrhagic telangiectasia.
Not available
S-EPMC6014448 | biostudies-literature
UnknownNeurovascular manifestations in hereditary hemorrhagic telangiectasia: imaging features and genotype-phenotype correlations.
Not available
S-EPMC4433843 | biostudies-literature
UnknownThe ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
Not available
S-EPMC4449292 | biostudies-literature
UnknownMachine learning to predict early recurrence after oesophageal cancer surgery.
Not available
S-EPMC7299663 | biostudies-literature
UnknownMutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.
Not available
S-EPMC5957269 | biostudies-literature
UnknownMulti-Omic Analysis of Esophageal Adenocarcinoma Uncovers Candidate Therapeutic Targets and Cancer-Selective Posttranscriptional Regulation.
Not available
S-EPMC11245951 | biostudies-literature
Sort   by:  
 Page size